Hhhy77ikrq2nwoiooicp screen shot 2018 05 10 at 7.40.42 am

MD Biosciences

About MD Biosciences

Founded: 1991 Type: Privately Held Size: 51-200 employees

MD Biosciences is an industry-leading provider of preclinical, translational and clinical-phase contract research services for the development of pharmaceutical and diagnostic assets. Established in 1991, MDB offers expertise, services and products across a wide range of therapeutic areas including inflammatory diseases, autoimmunity, neurology, oncology, metabolism, and pain. We collaborate with companies of all sizes, from small start-ups to large pharmaceutical pioneers, for the development of innovative therapeutics and diagnostic assays.

Our AAALAC-accredited and GLP-compliant preclinical facilities are state-of-the-art in technical capabilities for in vitro and in vivo studies, while our CLIA-certified diagnostic facilities support clinical investigations through fit-for-purpose assay design and validation. Our translational services bridge the gap between basic research findings and potential clinical utility, and include offerings such as application of unique biomarker signatures, selection or stratification of specific patient populations and mechanism of action determination. Additionally, we offer large-animal porcine models which demonstrate higher translatability of preclinical findings to the clinic, providing a more accurate representation of human anatomy and physiology.

Czhbvixsmuv1ds0fivqw mdbio

MD Biosciences Preclinical Laboratory Services

Oakdale Minnesota
32 Orders Completed 100% Positive
Jjhg3xxiszkhbpaynptq mdbio

MD Biosciences Clinical Laboratory Services

Oakdale Minnesota
Orders Completed 100% Positive